Compare GFI & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GFI | A |
|---|---|---|
| Founded | 1887 | 1999 |
| Country | South Africa | United States |
| Employees | 6560 | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.4B | 39.8B |
| IPO Year | N/A | 1999 |
| Metric | GFI | A |
|---|---|---|
| Price | $59.02 | $124.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 16 |
| Target Price | $45.71 | ★ $165.13 |
| AVG Volume (30 Days) | ★ 3.4M | 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.11% | 0.82% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | N/A | ★ 4.57 |
| Revenue | N/A | ★ $4,472,000,000.00 |
| Revenue This Year | $33.88 | $8.03 |
| Revenue Next Year | N/A | $6.22 |
| P/E Ratio | ★ $25.02 | $27.22 |
| Revenue Growth | N/A | ★ 6.43 |
| 52 Week Low | $18.25 | $96.43 |
| 52 Week High | $61.52 | $160.27 |
| Indicator | GFI | A |
|---|---|---|
| Relative Strength Index (RSI) | 60.70 | 35.42 |
| Support Level | $22.57 | $121.63 |
| Resistance Level | $61.52 | $126.44 |
| Average True Range (ATR) | 2.14 | 3.21 |
| MACD | 0.16 | -0.05 |
| Stochastic Oscillator | 96.42 | 23.84 |
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.